MedPlus Health Services shares fell over 3.6 pre cent after its subsidiary, Optival Health Solutions, received a 15-day drug license suspension at a Karnataka store, potentially affecting revenue. Despite setbacks, CareEdge reaffirmed its financial ratings for the company’s bank facilities

Mumbai: Shares of MedPlus Health Services slipped over 3.6 per cent on the BSE, touching an intra-day low of Rs 755.3 per share on Monday. However, later in the day, the stock recovered and was trading 2.42 per cent lower at Rs 765 per share. The company’s market capitalisation stood at Rs 9,166.43 crore. The fall in MedPlus shares came after its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a drug license at one of its stores in Karnataka.

According to the stoc

See Full Page